On Nov 21st we attended MEDVIA’s Science for health: Advancing Gene Therapy to showcase how the Biodevice collaboration between Antleron, Comate and ICsense enables solutions for scalable bioprocesses.
The day was packed with presentations and networking sessions, all to advance gene therapy in Belgium and beyond. While the field has moved forward, certain challenges remain and together with our partners we are working hard to address them.
Biodevice is an initiative, supported by the MEDVIA cluster, to develop a toolbox to fast-track development of modular, customized, scalable bioprocess devices to enable manufacturable solutions for cell, gene, and diagnostics companies.